e-learning
resources
Milan 2017
Monday, 11.09.2017
Experimental PH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Dasatinib increases endothelial permeability leading to pleural effusion
C. Phan (le kremlin bicetre dedex, France)
Source:
International Congress 2017 – Experimental PH
Session:
Experimental PH
Session type:
Thematic Poster
Number:
2375
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Phan (le kremlin bicetre dedex, France). Dasatinib increases endothelial permeability leading to pleural effusion. 2375
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The diagnostic value of vascular endothelial growth factor in pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 246s
Year: 2004
Pleural fibrosis and thickening in a sheep empyema model leads to 21% decrease of pleural permeability
Source: Eur Respir J 2006; 28: Suppl. 50, 636s
Year: 2006
Mechanisms controlling the volume of pleural fluid and extravascular lung water
Source: Eur Respir Rev 2009; 18: 244-252
Year: 2009
The role of vascular endothelial growth factor in tuberculous and parapneumonic pleural effusions
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008
Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity
Source: Eur Respir J 2016; 48: 1517-1519
Year: 2016
Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF
Source: Eur Respir J 2006; 28: Suppl. 50, 551s
Year: 2006
Vascular endothelial growth factor (VEGF) in malignant and tuberculous pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001
The role of aquaporin-1 in the formation of pleural effusion
Source: Eur Respir J 2005; 26: Suppl. 49, 553s
Year: 2005
Host-derived osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008
Angiopoietin-2 levels are elevated in exudative pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005
Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007
Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 39: 133-140
Year: 2012
Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 133-140
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept